Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News in Healthcare

Articles with a lock require a GLG News subscription.
Michael WolffOctober 17, 2008
Oxybutinin gel will fill a niche in OAB treatment
Analysis of: Watson Announces Positive Data for Its Investigational Oxybutynin Topical Gel for the Treatment of Overactive Bladder at SUNA's Annual Conference | www.pipelinereview.com
Author: Michael Wolff, Urologist, Alamance Regional Medical Center, Inc
Ditropan XL and generic ditropan have significant side effects and oxytrol patches can cause skin irritation. These problems may be avoided with oxybutinin gel.
October 16, 2008
Does this dosage form really add anything?
Analysis of: Watson Announces Positive Data for Its Investigational Oxybutynin Topical Gel for the Treatment of Overactive Bladder at SUNA's Annual Conference | www.pipelinereview.com
Author: GLG Expert Contributor
The comparator product to oxybutynin topical gel (OTG) is Ditropan XL which is also a once daily drug.
October 15, 2008
Thyroid cancer: When it rains it pours
Analysis of: Phase II Trial of Sorafenib in Advanced Thyroid Cancer | jco.ascopubs.org
Author: GLG Expert Contributor
 as per an accompanying editorial "In conclusion, it is particularly gratifying that years of research in tumor biology and drug development have coalesced. Translation of these research advances into therapeutic benefits for patients with refractory thyroid cancer, and a related paradigm shift in the treatment of these tumors, appear not far off. Support of well-designed clinical trials will...
October 15, 2008
Genetically determined cancer therapy: It will be a wash.
Analysis of: Genetic Research May Help Pick Patients' Best Cancer Drugs | online.wsj.com
Author: GLG Expert Contributor
Genetic determinants will decrease use of some drugs due to mutations such as Kras which indicate less chance of response and thus the chemo agents will not be used.
October 14, 2008
End of Era: Abbott's Attempt.
Analysis of: Abbott: Clinical trial shows stent 'does its job' | www.forbes.com
Author: GLG Expert Contributor
Currently, bioabsorbable stents do not provide better solution than traditional stents for the major problems of early thrombosis and absence of long term advantage compared with medical management (in appropriate patients).
October 14, 2008
Great Relieve: not Stroke, only Death and Heart Attack.
Analysis of: Data show no stroke risk with Pfizer lung drug: FDA | www.reuters.com
Author: GLG Expert Contributor
The risks of death and myocardial ischemia have not been disproved. The data of stroke possibility was not finalized by FDA.
Adam FeinOctober 14, 2008
Dangers of Rogue Online Pharmacies
Analysis of: Online Overdose | columbusdispatch.com
Author: Adam Fein, Founder & President, Pembroke Consulting Inc
The Columbus Dispatch published a six-part expose/overview about the diversion and sale of controlled substances. Mike Pramik, the reporter who wrote all six parts, has pulled together a must-read series. Since the Dispatch is also Cardinal Health’s (CAH) hometown paper, there are some good insights into the ways that Cardinal has dealt with the challenges of selling to potential rogue Internet pharmacies....
October 14, 2008
Without therapeutics, genetic disease diagnostics have limited use
Analysis of: Study to Track How People React to Disease-Risk Data | online.wsj.com
Author: GLG Expert Contributor
Genetic testing is an important emerging tool for patients, drug researchers, physicians, and healthcare providers. However, without therapeutics or some way to act on the data, such a study is unlikely to uncover behaviors that provide key insights. Nevertheless, this data would aid researchers and investors who rely on poor prevalence data to make R&D investment decisions.
Steve DavisOctober 14, 2008
St. John's Wort: As good a s prescription drugs
Analysis of: St John's Wort 'as good as Prozac' | ukpress.google.com
Author: Steve Davis, Director of Radiology, Clarendon Memorial Hospital Inc
St. John's Wort has been used for many years by herbalists to treat the symptoms of depression. Most herbal references I have reference it as a treatment for depression. The products are not regulated and therefore could contain different levels of the active ingredient. As well, the standard dosages may vary from vendor to vendor. Having used St. Johns Wort I can say from personal experience, while...
October 13, 2008
St. John's Wort vs Prozac
Analysis of: St John's Wort 'as good as Prozac' | ukpress.google.com
Author: GLG Expert Contributor
St. John's Word is an effective herb and has been used for centuries.  Heed some warnings and take care of your whole body, mind and spirit. 
Previous Page : 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Next151 to 160 of 5570

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T17:45:17.163